About: Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2014 (uk) im September 2014 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q58948155-510F60C0-CA75-4B1C-B778-D53F192578F8
publication date	2014-09-04 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58948155-ADD22C93-DC4D-4974-A1C7-2DEBE32D4B77
language of work or name	English
exact match	wds:Q58948155-011F41B8-E234-436A-9965-BA0AD571C585
exact match	https://scigraph.springernature.com/pub.10.1007/s00198-014-2872-5
cites work	wds:Q58948155-020F70CA-70C8-4F44-BD2C-CB4EFF15ED63 wds:Q58948155-0AD15F9C-8BC9-4DEF-804B-396CEE5F147F wds:Q58948155-1F24E0F5-CB74-415B-AD86-6299C4FF38C9 wds:Q58948155-3CF4C1E7-6E48-49E3-808B-B2B462644950 wds:Q58948155-3D7A506E-CBBF-40BD-BC21-5A4061969857 wds:Q58948155-5482F99E-2305-45E4-BD9F-337B53E9EDB8 wds:Q58948155-5A4E7EB2-A401-4867-8D51-62F212C440E1 wds:Q58948155-63E588E1-F720-4B6C-ABB8-98814C71F19E wds:Q58948155-64556279-1F5B-483D-A485-584F28E469C1 wds:Q58948155-7B27B461-E219-4FA0-85EE-EDB16D7ED05E wds:Q58948155-9B49874C-F99E-4FE6-B7AD-190EEFC43C86 wds:Q58948155-A4872F07-1B1F-4B56-99DD-7D80CCBF046E wds:Q58948155-A95572E6-5CA5-4312-B87D-B006BA6431E3 wds:Q58948155-AA62CB5A-9DC8-457C-ADCC-898852CDDB88 wds:Q58948155-B2667290-A769-4DA5-8DE0-B1E4D1BC8328 wds:Q58948155-BCFCC6C5-511C-4216-A83F-084977CC4086 wds:Q58948155-CC9619ED-AF09-4D15-821A-933A7F2638B3 wds:Q58948155-D67A6F4A-156A-4433-8C0F-B5B93AADD505 wds:Q58948155-E26528FE-E9DB-4A05-A1FF-B27A7DFE8975 wds:Q58948155-FE4B8320-F7A1-45B6-8BCF-EB1F901E2A6C
cites work	Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis Zoledronic acid and clinical fractures and mortality after hip fracture Pamidronate disodium and possible ocular adverse drug reactions Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP. Gamma/delta T-cell stimulation by pamidronate Bisphosphonates and ocular inflammation Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. The incidence of acute anterior uveitis after intravenous zoledronate. Orbital inflammatory disease in a patient treated with zoledronate Clodronate induced uveitis Bilateral acute uveitis and conjunctivitis after zoledronic acid therapy The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis Characterization of and risk factors for the acute-phase response after zoledronic acid Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate. Corneal graft rejection precipitated by uveitis secondary to alendronate sodium therapy Serious ocular complications of zoledronate Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England.
author name string	wds:Q58948155-54728E76-1143-4E69-9BA7-46E9CD5A62A4 wds:Q58948155-5C3262A8-39DD-45CC-B206-0BED905F3833 wds:Q58948155-F6C279C8-9564-478D-8310-8662281B4852
author name string	M Singh Z Nisa F Al-Abuwsi
rdfs:label	Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial (en) Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial (nl)
skos:prefLabel	Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial (en) Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial (nl)
name	Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial (en) Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial (nl)
author	wds:Q58948155-1AFE99BE-BA8B-4E0B-87D8-A9311EA3DC4D wds:Q58948155-388E9B30-D8B1-4565-8523-CA1EE552CFDC wds:Q58948155-C92ACD15-EB77-4CE5-B07C-76374C05788F wds:Q58948155-D1591FB0-0B13-46D6-8067-9FF865DEE262 wds:Q58948155-F79A69ED-9B98-4F25-901B-481467EDD2F6
author	Dipika V. Patel Charles N J McGhee Mark Bolland Anne Horne Ian Reid
title	wds:Q58948155-FF16E614-1D4E-4A8A-A519-3DD42FA1CC1B
title	Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial (en)
page(s)	wds:Q58948155-15FA0FC5-F374-4F28-8A5D-118A174E4795
page(s)	499-503
instance of	wds:Q58948155-C8FFF9C0-FFD7-49C9-8BA1-0D30A9D31177
instance of	scholarly article
main subject	wds:Q58948155-A401B7F3-7AAB-4794-BAF7-C2E2D87AAC93
main subject	randomized controlled trial
PubMed ID	wds:Q58948155-3A8F3A26-62C2-445C-996F-6CDDAF5901AB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25187119
PubMed ID	25187119
published in	wds:Q58948155-AE7DBE23-E9F2-40BB-8FB6-72DA5200ED81
published in	Osteoporosis International
issue	wds:Q58948155-7ED450B7-63A1-45F8-AA08-E5648DB780C4
volume	wds:Q58948155-33B1C764-12A2-4F0E-8F31-2D9DC0951E93
issue	2
volume	26
DOI	wds:Q58948155-0F3B4AE5-5D29-4BB1-94AD-9240E458ECD2
DOI	http://dx.doi.org/10.1007/S00198-014-2872-5
DOI	10.1007/S00198-014-2872-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58948155
is cites work of	The Effects of Re-challenge in Patients with a History of Acute Anterior Uveitis Following Intravenous Zoledronate Drugs, Inflammation, and the Eye. Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report [Zoledronate-induced panuveitis] Acute Bilateral Anterior Uveitis after a Single Intravenous Infusion of Zoledronic Acid in Metastatic Breast Cancer Risk of Cataract Surgery and Age-Related Macular Degeneration After Initiation of Denosumab vs Zoledronic Acid for Osteoporosis: A Multi-Database Cohort Study

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software